Skip to content

A pilot study on the use of Ketocal Infant in administering the ketogenic diet

A pilot study on the use of Ketocal Infant in administering the ketogenic diet - Ketocal Infant Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33509
Enrollment
4
Registered
2009-09-22
Start date
2010-01-08
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

childhood epilepsy refractory epilepsy

Interventions

Replacement of the usual formula into Ketocal Infant formula and therefore changing from carbohydrate to fat burning for energy supply. This results in state of ketosis which can influence the seizu

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Infant aged 0-24 clinical indication for use of the ketogenic diet for either treatment of epilepsy or disorder of carbohydrate metabolism responsive to the ketogenic diet will take the majority of prescribed calorie intake from Ketocal Infant (70-100%) Informed consent obtained

Exclusion criteria

Exclusion criteria: infant over 24 months presence of other acute ilness like vomiting, sepsis diabetes mellitus metabolic disorders such a fatty acid disorders carnitine deficiency Pyruvate carboxylase deficiency ketotic hypoglycemia clinical suspicion of mitochondrial enzym deficiency less than 70% of intake of prescribed calorie requirements from Ketocal Infant milkintolerance Unable to adhere to protocol instructions investigators uncertainty about willingness of ability of the subject to comply with the protocol requirements

Design outcomes

Primary

MeasureTime frame
intake and tolerance will be assassed by - comparising of the amount of Ketocal Infant consumed versus prescribed intake - documentation of tolerance to Ketocal Infant by the prescriber with due considerations given to intake and effect on GI symptoms (constipation, diarrhoea, vomiting )

Secondary

MeasureTime frame
Seizure and ketosis effect by - bloodketones to determine the effect of Ketocal Infant on ketosis - Seizure type and frequency recorded to determine effect on seizure reduction - Effect on symptoms ( level of sedation, muscle tone ) and reduction in medication will be recorded Growth will be measurede and recorded by - weight - length - head circumference

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)